Formulation of cost-effective medium and optimization studies for enhanced production of rapamycin
Crossref DOI link: https://doi.org/10.1186/s12934-023-02201-3
Published Online: 2023-09-20
Update policy: https://doi.org/10.1007/springer_crossmark_policy
K. Ganesh, Sanjeev.
C, Subathra Devi
Text and Data Mining valid from 2023-09-20
Version of Record valid from 2023-09-20
Article History
Received: 28 July 2023
Accepted: 6 September 2023
First Online: 20 September 2023
Declarations
:
: The authors declare no competing interests.
: Not applicable.